TissueTech is a biotechnology company that develops regenerative medicine and proprietary technology. It offers amniotic tissue-based products for use in regenerative tissue therapies for ocular surface, musculoskeletal diseases, and disorders. The solutions are applied in ophthalmology and wound care markets.
|HQ||Miami, FL, US||Map|
|Employees (est.) (Sept 2021)||245||(-1%)|
TissueTech total Funding
TissueTech latest funding size
Time since last funding
|2 years ago|
|River Cities Capital Funds, Ballast Point Ventures, Essex Woodlands Healthcare Partners|
When was TissueTech founded?
TissueTech was founded in 2001.
Who are TissueTech key executives?
TissueTech's key executives are Amy Tseng, Scheffer C.G. Tseng and Devin Buckley.
How many employees does TissueTech have?
TissueTech has 245 employees.
Who are TissueTech competitors?
Competitors of TissueTech include MiMedx Group, Rebiotix and RayzeBio.
Where is TissueTech headquarters?
TissueTech headquarters is located at 7300 Corporate Center Dr #700, Miami.
Where are TissueTech offices?
TissueTech has offices in Miami and Doral.
How many offices does TissueTech have?
TissueTech has 2 offices.
Receive alerts for 300+ data fields across thousands of companies